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Haematuria on the Spanish 
Registry of Glomerulonephritis
Claudia Yuste1, Francisco Rivera2, Juan Antonio Moreno3,* & Juan Manuel López-Gómez1,*
Recent studies suggest a pathogenic role for glomerular haematuria among renal function. However, 
there is no data on the prevalence of haematuria from a large renal biopsy registry. We analysed the 
prevalence of gross (GH) and microscopic (mH) haematuria in 19,895 patients that underwent native 
renal biopsies from the Spanish Registry of Glomerulonephritis. Haematuria’s overall incidence was 
63% (GH 8.6% and mH 55.1%), being more frequent in males (64.7% vs. 62.4%). GH was more prevalent 
in patients <18 years (21.3% vs. 7.7%). The commonest clinical presentation associated with GH was 
acute kidney injury (31.5%) and IgA Nephropathy (IgAN) (33.6%) was the most frequent histological 
finding. GH patients showed a significantly (p < 0.05) lower eGFR and proteinuria levels as compared 
with patients with mH and without haematuria. Moreover, mH was more prevalent in adults (56.3%). 
Nephrotic syndrome was the commonest clinical presentation in mH patients (32.2%) and IgAN (18.5%) 
the most frequent histological finding. In conclusion, haematuria, is a frequent urinalysis finding in 
patients underwent native renal biopsy. The most frequent histological finding in both GH and mH is 
IgAN. Whereas, GH is more frequent in young males with acute kidney injury, mH is commoner among 
adults with nephrotic syndrome.
Haematuria is defined as the presence of more than 2–5 red blood cells (RBCs) per high-power field in the urine1. 
Haematuria is called macroscopic or gross haematuria (GH) when there is massive presence of RBCs in the urine 
being identified by the naked eye, whereas microscopic haematuria (mH) can only be detected by microscopi-
cally examination of urine sediment. The presence of dysmorphic RBCs in the urine distinguish the glomerular 
origin of haematuria2. Glomerular haematuria is associated with glomerular filtration barrier (GFB) dysfunction 
or damage, as reported in renal diseases associated with abnormalities in GFB components or in inflammatory 
diseases where proteolytic enzymes released by inflammatory cells may degrade GFB components, thus leading 
to a more fragile GFB that is more susceptible to rupture, as seen in primary glomerulonephritis, autoimmune 
diseases, or infections3.
Haematuria has been used as a marker of renal disease activity and it is considered as one of the hall-
marks of some glomerular diseases, such as IgA Nephropathy (IgAN), Alport syndrome (AS), Endocapillary 
GN, Membranoproliferative (MPGN) and Crescentic GN, but rather unusual in other nephropathies includ-
ing Minimal Change Disease (MCD), Focal and Segmental Glomerulosclerosis (FSGS) and Membranous 
Nephropathy (MN)4–6. Although glomerular haematuria has been traditionally considered a benign condition, 
it has been recently associated with a negative renal function outcome in the short7,8 and long-term9,10. Therefore 
is however no robust data on the prevalence of haematuria among patients with renal dysfunction that have 
undergone renal biopsy, or its relationship with other glomerular injury markers, such as proteinuria and serum 
creatinine.
In this study we aimed to investigate the prevalence of gross and microscopic haematuria and its association 
with clinical and histological findings in 19,895 patients collected in the Spanish Registry of Glomerulonephritis 
between 1994 and 2013.
Results
The clinical characteristics of the 19,895 patients who underwent native renal biopsy are shown on Table 1. 
Haematuria was present in 12,683 patients (63.7%), of whom 1,717 patients presented with GH (8.6%) and 10,966 
patients with mH (55.1%). Patients with GH were significantly younger than the ones with mH and those without 
haematuria (p < 0.05). Haematuria was more frequent in males than in females (64.7% vs. 62.4%, p < 0.05). GH 
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patients presented significant higher serum creatinine concentration and lower eGFR and proteinuria levels than 
patients with mH or NH. Hypertension was found in 53.5% patients, being significantly more frequent in mH as 
compared with GH and NH patients.
Evolution of biopsies over 2 decades. The total number of biopsies fluctuated during the 20 years ana-
lysed in our study (Supplementary Table 1). The prevalence of haematuria decreased with time, due to a decrease 
presence in the number of mH cases. However, mH remained the commonest urinalysis finding throughout. We 
observed a progressive increase in age of the patients who underwent renal biopsy, from 44.2 ± 20.2 years in the 
beginning of the nineties to 52.0 ± 18.4 years in the last period. This aging was especially striking in GH patients 
(from 38.6 ± 23.4 years to 52.8 ± 19.9 years, p < 0.05). The eGFR at the time of the biopsy decreased progres-
sively during the study (from 53.7 ± 38.4 to 48.8 ± 36.2 ml/min), being especially noticeable in GH cohort (from 
55.9 ± 47.9 to 37.9 ± 34.3 ml/min), while the eGFR at time of biopsy in NH group remained stable. The level 
of proteinuria fluctuated during the 5 time-points of the study and in relation of the presence of haematuria, it 
increased in GH patients, but remained stable in both mH and NH patients.
Renal syndromes and urinalysis finding. The main renal syndrome at the time of the renal biopsy in the 
whole Registry was nephrotic syndrome (35.3%), followed by AUA (21.3%), and AKI (18.9%). The most common 
renal syndrome among GH patients was AKI, while nephrotic syndrome was the most frequent syndrome in mH 
and NH patients (Fig. 1).
On the other hand, haematuria was found in the 54.1% of patients with nephrotic syndrome, mainly mH 
(Fig. 2). Similarly, mH was also significantly more frequent than GH in the patients with Nephritic syndrome. 
Almost 65% of AKI patients presented with haematuria, mainly mH. Additionally, 58.8% of CKD patients had 
haematuria. (Fig. 2).
Urinalysis findings according to gender and age groups. Microscopic haematuria was the most com-
mon urinalysis finding, independently of age or gender (Fig. 3). Haematuria was more frequent in young patients 
(70.7%, < 18 years vs. 63.1%, > 18 years), especially in the GH group (21.3%, < 18 years vs. 7.7%, > 18 years). The 
urinalysis findings in the childhood and adolescent cohort were significantly different from the over 18 years of 
age (GH 20.7%/mH 50%/NH 29.3% vs. GH 8%/mH 54.6%/NH 37.4%, respectively). Elderly males (66–80 years) 
presented a higher GH prevalence compared with young adults (19–40 years) and adults (41–65 years) (10.1% 
vs. 8.7% and 7.6%, p < 0.05, respectively). Similarly, elderly women also presented higher prevalence of GH than 
young adult females (GH 7.2% vs. 5.7%). Patients aged more than 80 years presented similar urinalysis findings 
than young adults and adults in both genders (Fig. 3).
All N = 19895 GH N = 1717 mH N = 10966 NH N = 7212 p
Age (years) 48.3 ± 19.5 45.8 ± 22.3 48.3 ± 18.9a 49.6 ± 19.0a,b < 0.0001
Gender (Male) 60.1% 67.2% 59.9%a 58.6%a < 0.0001
Hypertension (Yes) 53.5% 45.8% 55.5%a 53.7%a,b < 0.0001
Creatinine (mg/dL) 2.62 ± 2.84 3.32 ± 3.19 2.56 ± 2.74a 2.51 ± 2.75a < 0.0001
eGFR (mL/min) 50.4 ± 36.7 46.6 ± 41.6 50.5 ± 36 51.3 ± 36.4b 0.015
Proteinuria (g/day) 4.09 ± 4.61 3.09 ± 4.19 3.96 ± 4.49a 4.52 ± 4.83a,b < 0.0001
Table 1.  Clinical characteristic at the time of native renal biopsy according to urinalysis findings. eGFR, 
estimated glomerular filtration rate; GH, gross haematuria; mH, microscopic haematuria; NH, non haematuria. 
Where a indicate statistical difference with GH, and b indicate statistical difference with mH.
Figure 1. Indication for native renal biopsy according with urinalysis. GH, Gross Haematuria; mH, 
Microscopic Haematuria; NH, Non Haematuria; CKD, Chronic Kidney Disease; AKI, Acute Kidney Injury; 
AUA, Asymptomatic Urinary Abnormalities.
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Histopathological findings according to degreed of haematuria. IgAN was the most common his-
tological diagnosis in our study, followed by Crescentic GN, MN, Lupus Nephritis (LN) and FSGS (Table 2). IgAN 
was the most common histological diagnosis in GH patients, followed by Crescentic GN and MPGN, Mesangial 
non IgA and LN. The principal diagnosis in mH cohort was also IgAN, closely followed by Crescentic GN, LN 
and MN. On the other hand, the most frequent histological finding in NH patients was MN, followed by MCD, 
LN and FSGS.
When we analysed the presence of haematuria in primary glomerulonephritis, we found that almost 90% 
of all IgAN patients had haematuria, usually mH (Fig. 4). Similarly, haematuria was present in almost 80% of 
Crescentic GN, 72.6% of MPGN and 70% of Endocapillary GN (Fig. 4).
After working out the percentage of GH vs mH for each singular aetiology we observed that the highest 
GH percentages were among patients with anti-glomerular basement membrane (anti-GBM) disease, type 2 
Crescentic GN and Endocapillary GN; whereas the highest mH percentages were associated with IgAN, 
ANCA-vasculitis and MPGN (Table 3). Finally, haematuria was presented in 41% of both acute and chronic 
tubulointerstitial nephritis.
Logistic regression reported that youth, male gender, low proteinuria and impaired eGFR were independent 
risk factors associated to both GH and mH. After stratification of patients according to age, our results show that 
male gender, low proteinuria and impaired eGFR were independent risk factors for GH, especially in patients 
Figure 2. Urinalysis finding according with the main renal syndrome. GH, Gross Haematuria; mH, 
Microscopic Haematuria; NH, Non Haematuria; CKD, Chronic Kidney Disease; AKI, Acute Kidney Injury; 
AUA, Asymptomatic Urinary Abnormalities; Isolated H, isolated haematuria; Recurrent H, recurrent 
haematuria.
Figure 3. Urinalysis findings according gender and age groups. GH, Gross Haematuria; mH, Microscopic 
Haematuria; NH, Non Haematuria. Where * represents statistically significant differences on the urinalysis 
findings between genders in the same age group. Where a represents the differences with the < 18 year-old male 
group, b differences with the 19–40 year-old male group and c differences with the 41–65 year-old male group. 
Where d represents differences with the < 18 year-old female group and e differences with the 19–40 year-old 
female group.
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n % n % n % n %
IgAN 2922 14.7 577 33.6 2029 18.5 316 4.4
Crescentic GN 2085 10.5 373 21.7 1260 11.5 452 6.3
MPGN 799 4.0 85 4.9 519 4.7 195 2.7
Mes non IgA 672 3.4 69 4 416 3.8 187 2.6
LN 1876 9.4 68 4 1110 10.1 698 9.7
FSGS 1632 8.2 66 3.8 868 7.9 698 9.7
Unclassifiable 862 4.3 62 3.6 441 4 359 5
Endocapillary 244 1.2 51 3 121 1.1 72 1
MN 2012 10.1 49 2.9 1066 9.7 897 12.5
MCD 1337 6.7 42 2.4 566 5.2 729 10.1
Amiloidosis 714 3.6 31 1.8 272 2.5 411 5.7
ATIN 611 3.1 30 1.7 217 2 364 5.1
HN 860 4.3 27 1.6 429 3.9 404 5.6
ATN 236 1.2 24 1.4 100 0.9 112 1.6
Cryoglobulinemia 111 0.6 22 1.3 65 0.6 24 0.3
TMA 144 0.7 17 1 90 0.8 37 0.5
DN 745 3.7 16 0.9 337 3.1 392 5.4
CTIN 430 2.2 16 0.9 160 1.5 254 3.5
MHT 191 1 12 0.7 104 0.9 75 1
Esclerosis 430 2.2 12 0.7 271 2.5 146 2
Fibrillary GN 43 0.2 3 0.2 20 0.2 20 0.3
MM 200 1 3 0.2 99 0.9 98 1.3
Alport S 31 0.2 2 0.1 25 0.2 4 0.1
ChE 45 0.2 1 0.1 20 0.2 24 0.3
Others 677 3.4 73 4.2 361 3.2 243 3.4
Total 19895 % 1717 8.6 10966 55.1 7212 36.3
Table 2.  Relationship between urinalysis findings and kidney biopsy. IgAN, IgA Nephropathy; MPGN, 
Membranoproliferative GN; Mes non IgA, Mesangial non IgA; LN, Lupus Nephritis, FSGS, Focal Segmental 
Glomerulosclerosis; MN, Membranous Nephritis; MCD, Minimal Change Disease; MHT, Malignant 
Hypertension; ATIN, Acute Tubulointerstitial; Nephritis; ATIN, Acute Tubulointerstitial Nephritis; ATN, acute 
tubular Necrosis; HN, hypertensive Nephropathy; CTIN, Chronic Tubulointerstitial Nephritis; DN, Diabetic 
Nephropathy; TMA, Thrombotic Microangiopathy; Alport S, Alport Syndrome; ChE, Cholesterol embolism; 
MM, Multiple Myeloma.
Figure 4. Primary Glomerulonephritis according with its urinalysis presentation. GH, Gross Haematuria; 
mH, Microscopic Haematuria; NH, Non Haematuria; IgAN, IgA Nephropathy; FSGS, focal and segmental 
glomerulosclerosis.
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older than 18 years. However, male gender was only an independent risk factor for mH in patients older than 18 
years. Low proteinuria and impaired eGFR were associated with mH disregarding the age (Table 4).
Discussion
We found a high incidence of glomerular haematuria in patients who underwent native renal biopsy. The majority 
presented with microscopic haematuria. The gross haematuria cohort included mostly males, during childhood 
and adolescence, and this was usually associated to AKI. Whereas the incidence of microhaematuria was higher 
in adults presenting with nephrotic syndrome.
Our findings regarding clinical presentation and histological diagnosis in biopsy-proven renal diseases are 
consistent with data reported from other European countries11–13. The most common indication for renal biopsy 
worldwide, as well as in our cohort, is nephrotic syndrome14–17. Likewise, we found that IgAN is the most com-
mon primary glomerulonephritis. This is in agreement with data from Western Europe11,12,18. Though studies 
from Eastern Europe19 and sub-Saharan Africa16 found MPGN to be most frequent diagnosis of glomerulone-
phritis. This finding is thought to be related to socioeconomic status.
Although is commonly accepted that glomerular haematuria indicates GFB dysfunction, its usefulness as 
glomerular injury marker is not properly established and so it is not formally included as a biopsy criterion in the 
KDIGO Clinical Practice Guidelines20. Similarly, although it has been suggested that early identification of glo-
merular disease optimizes treatment and may be beneficial on early CKD stages there is no consensus on whether 
biopsy should be performed in patients with haematuric glomerular diseases21,22. Recent evidences reported that 
persistent isolated haematuria increased 18-fold the risk of ESRD9, mainly due to primary glomerular diseases, 
pointing that persistent mH could be an early feature of glomerulonephritis. However, Gutierrez et al. suggested 
that biopsy assessment would be an unnecessary procedure in IgAN patients with minimal proteinuria and hae-
maturia based on the good prognosis of the condition23. It is important however, to note that almost 33% of the 
IgAN cohort with GH bouts did not recover basal renal function after an AKI episode, inferring that renal biopsy 
should be only recommended in these IgAN patients7. On the other hand, renal biopsy is still mandatory in at 
least one member of a family affected with familial haematuria, whereas molecular testing may be performed in 
the remaining affected members22. In our opinion, and based on the high prevalence of haematuria in glomerular 
diseases found in our study, every patient with persistent mH should be carefully investigated to rule out primary 
and secondary glomerulonephritis. Moreover, renal biopsy should be performed a whenever patients present with 
haematuria associated with AKI, an episode of GH, heavy proteinuria23 or RBCs cast.
The real incidence of haematuria in the general population is uncertain, ranging from 0.18 to 16.1% in 
adults24,25 and from 0.03–1.5% in children9,26–28. These wide ranges could be explained by differences in gender, 
GH mH NH
% % %
Anti-GBM disease 29.9 IgAN 69.4 ATIN 59.6
Type 2 Crescentic 23.4 ANCA-Vasculitis 68.4 CTIN 59.1
Endocapillary 20.9 MPGN 62.3 Amyloidosis 57.7
IgAN 19.7 FSGS 53.2 MCD 54.4
Mes non IgA 10.3 MN 53 MM 53.7
Table 3.  Top five histological diagnoses in patients presenting GH, mH and NH. Anti-GBM, anti-
glomerular basement membrane, IgAN, IgA Nephropathy; MPGN, Membranoproliferative GN; Mes non IgA, 
Mesangial non IgA; FSGS, Focal Segmental Glomerulosclerosis; MN, Membranous Nephritis; MCD, Minimal 
Change Disease; ATIN, Acute Tubulointerstitial; Nephritis; ATIN, Acute Tubulointerstitial Nephritis; CTIN, 
Chronic Tubulointerstitial Nephritis; MM, Multiple Myeloma.
All <18 years >18 years
B p B p B p
Independent risk factors for GH
 Age − 0.012 < 0.01
 Male Gender 0.13 0.034 0.59 < 0.001 0.279 < 0.001
 Proteinuria − 0.014 0.08 − 0.13 < 0.001 − 0.048 < 0.001
 eGFR 0.002 < 0.001 − 0.001 0.052 − 0.01 < 0.001
Independent risk factors for mH
 Age − 0.007 < 0.001
 Male Gender 0.08 0.049 0.058 0.66 0.06 0.047
 Proteinuria − 0.026 < 0.001 − 0.034 0.011 − 0.026 < 0.001
 eGFR − 0.002 < 0.001 0.001 0.026 − 0.001 < 0.001
Table 4.  Independent risk factors for haematuria in adults and paediatric patients. Binary logistic 
regression for the risk of present GH vs NH and mH vs NH respectively. GH, Gross Haematuria; mH, 
Microscopic Haematuria; NH, Non Haematuria.
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age, race, socioeconomic status, and haematuria´s screening method. A higher prevalence of haematuria in 
biopsy registry studies has been reported. The occurrence of glomerular haematuria was 75.8% in 4004 Czech 
patients that underwent renal biopsy, where GH and mH were found in 9.2% and 65.9% of patients, respectively29. 
We observed a lower prevalence of haematuria (63.7%), and this may account for the lower percentage of mH 
(55.5%) in our cohort. These disparities could be explained by the fact that the Czech cohort was 10 years younger 
than ours (37.9 vs. 48.3 years) where one in four patients were younger than 18 years (vs. one in twenty-five in 
our cohort). In our study, haematuria was more frequent in male patients < 18 years, where GH ratio was 1.6:1 
compared with the 0.85:1 for mH. In agreement with our data, bouts of GH are more frequent in children with 
IgAN and Endocapillary GN30,31. Notably, almost all of the 75% of children diagnosed with IgAN presented GH 
bouts in the first years of the disease32. The GH rebound observed in our elderly population (66–80 years), could 
be attributed to the striking Crescentic GN incidence in this group33,34.
Furthermore, the occurrence of haematuria, mainly mH, decreased progressively over the 20 years of our 
study. In line with this reduction, we observed a progressive decrease in the eGFR and higher age of patients 
undergoing renal biopsy. This indicates a more conservative renal biopsy criteria in the last years, hence avoiding 
to carry out biopsies the young population without significant renal impairment or almost nephrotic proteinuria 
in spite of their haematuria.
Although the genesis of haematuria remains unknown, it has been proposed that mH could be secondary to 
RBCs passage through the GFB between the endothelial cell gaps35,36. This mechanism has been observed in both 
non-inflammatory renal diseases, such thin basement membrane nephropathy (TBMN)35, as well as in inflamma-
tory renal diseases, including MCD37, LN38, MN39, and focal40, and mild proliferative GN41. It has been suggested 
that an aggression over the GFB, irrespective of the cause, results in a weak point where the GFB could be easily 
open by even simple mechanical factors, as high intravascular pressure42. This hypothesis could explain the com-
mon association between nephrotic syndrome and haematuria observed in over the 55–66% of the patients29. On 
the other hand, breaks or holes in the glomerular capillary wall had been reported in necrotizing or crescentic 
forms of inflammatory GN35, presenting with GH. It has also been observed that during GH bouts in Alport syn-
drome patients there is a repaired glomerular basement membrane focal ruptures43. This considerable histological 
GFB injury could explain the high prevalence of GH in Anti-GBM disease and Endocapillary GN, as well as the 
high percentage of AKI patients presenting GH (31.5%), reported in our study. AKI is a common complication of 
severe GH44, with an incidence of 30% in IgAN patients45. After decades of considering GH bouts as an innocuous 
feature of glomerular diseases the negative implications of GH over renal outcome have been reported in IgAN46, 
AS22, and C3 Glomerulopathy47. These studies suggest that a better understanding of the role of haematuria on 
renal function outcome is necessary.
Haematuria has been classically considered as a hallmark of glomerular diseases, such as IgAN, Endocapillary, 
MPGN and Crescentic GN, but rather exceptional for some others, including MCD, FSGS and MN. Nevertheless, 
systematic reviews usually overlook to report the prevalence of haematuria6,48, even in IgAN30. Haematuria is the 
distinctive IgAN feature, usually presenting as persistent isolated mH, with occasional bouts of GH associated to 
infections. Haematuria´s prevalence in IgAN has been estimated at over 90% in patients with renal impairment, 
and almost 75% in patients with preserved renal function49. In agreement with our findings, haematuria is a usual 
feature of Endocapillary GN29,50 Crescentic GN31 and MPGN51. Our results also confirm previous reports4,52 of an 
unexpectedly high haematuria prevalence in traditionally considered non-haematuric glomerulonephritis MN, 
FSGS and MCD, pointing that the GFB injury that results in a heavy urinary protein leak, could as well allow 
RBCs egression.
The prevalence of haematuria in secondary glomerulopathies has not been formally reported. RBCs cast, 
but not haematuria, is a criterion for the diagnosis of systemic lupus erythematosus53, although haematuria is 
a common urinalysis finding54. Actually, isolated haematuria has been proposed as a marker of lupus activity55, 
associated with rapidly progressive glomerulonephritis54,56. However, mH is not a good biomarker of LN treat-
ment response57 or renal outcome58.
Interestingly, we also found a high prevalence of haematuria (around 40%) in tubulointerstitial diseases, such 
as ATIN and CTIN. Similarly, Fogazzi et al. reported the presence of haematuria in the 47.6% of ATIN patients 
and a high prevalence of RBCs casts in the urinalysis of these patients59. It has been proposed that the presence 
of RBCs in the urine may be a consequence of the interstitial inflammation, which would result in a disruption 
of interstitial blood vessels and further RBCs extravasation through gaps of the tubular membrane59. The same 
mechanism had been proposed to explain the haematuria of sickle cell disease60.
Haematuria seem to be more frequent in males22,30 with a reported 2:1 ratio in young males9. However, hae-
maturia is more frequent in TBMN females29 and some immune-mediated GN as LN12. Although there are some 
inherited nephropathies with X-linked transmission, such as X-linked Alport syndrome and Fabry disease, it is 
unknown why haematuria is more frequent in males. It is also unknown why males tend to progress faster than 
haematuric females in Alport Syndrome47, TBMN, C3 glomerulopathy22 and Fabry disease, but not in IgAN. In 
addition, we found that GH was more prevalent in males.
To our knowledge, this is the largest cohort study published on the prevalence of haematuria. It included renal 
biopsies, clinical presentation and histological diagnosis of haematuria over 20-year period. The main limitation 
of our study is related to the inherent heterogeneity of the cases recorded in a large multicentre renal biopsy reg-
istry, like the misclassification of some diseases that required electron microscopy diagnosis as TBMN and C3 
glomerulonephritis.
In conclusion, haematuria is a highly accessible glomerular injury marker usually present among patients with 
renal impairment justifying the need for native renal biopsy. The most frequent histological diagnosis in both GH 
and mH were IgAN and Crescentic GN. Gross haematuria is more frequent in young males and is usually associ-
ated to AKI, whereas the incidence of microhaematuria is higher in adults with nephrotic syndrome.
www.nature.com/scientificreports/
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Material and Methods
A total 21,240 first native renal biopsies from 156 different hospitals were included in this retrospective study of 
Spanish Registry of Glomerulonephritis, covering a period 1994 and 201333,61. We excluded those biopsies where 
urinalysis data was not recorded, so we finally studied 19,895 cases. Informed consent form was obtained from 
all the subjects, and the study was approved by the Local Ethics Committee of the Gregorio Marañon Hospital, 
Madrid, Spain, and performed in accordance with the Helsinki Declaration.
The description of the renal syndromes used as an indication for renal biopsy was previously reported62 and 
recorded as: (1) nephrotic syndrome defined as proteinuria > 3.5 g/day and serum albumin levels < 2.5 g/dL, 
(2) nephritic syndrome defined as oliguric acute kidney injury (AKI) accompanied by haematuria, proteinuria 
< 3.5 g/day and hypertension, (3) asymptomatic urinary abnormalities (AUA) defined as proteinuria < 3.5 g/day 
and/or haematuria and/or presence of casts, (4) AKI was defined as the increase in serum creatinine by 0.3 mg/dl 
within 48 hours; or the increase in serum creatinine more than 1.5 times baseline, which is known or presumed 
to have occurred within the prior 7 days; or urine volume lower than 0.5 ml/kg/h for 6 hours63, (5) chronic kidney 
disease (CKD) defined as abnormalities of kidney structure or function, present for 3 months, such as decreased 
on the estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2 64, (6) macroscopic isolated haematuria 
and (7) macroscopic recurrent haematuria.
The patients were categorized according to the presence of haematuria in urinary sediment, independently 
of the clinical manifestation, into: (1) gross haematuria (GH) when haematuria was obvious to the naked eye, 
(2) microscopic haematuria (mH) when the patient presented a positive dipstick, confirmed by microscopically 
examination, and (3) non haematuric (NH) when the sediment has < 2 erythrocytes/HPF65. We divided follow-up 
into five periods of 4 years to analyze the incidence of haematuria with time. Patients were also separated into 
5 groups according to age: (1) childhood and adolescence (< 18 years), (2) young adults (between 19–40 year), 
(3) adults (between 41–65 year), (4) elderly (between 66–80 years) and (5) very elderly (> 80 years). Glomerular 
filtration rate was estimated according to the MDRD equation66.
Statistical analysis. Each year, members of the Spanish Society of Nephrology up- date common data-
bases files (Microsoft Access® ). Normally distributed values are expressed as mean ± SD (standard deviation), 
whereas abnormal variables are expressed as median ± IQR (interquartile range). The normality of distribution 
was analyzed by using the Kolmogorov-Smirnov test. Comparison of categorical variables was performed using 
the chi-square. Continuous variables were compared using the Student’s t-test for two independent samples or 
by analysis of variance (ANOVA) when comparing more groups. Binary logistic regression were constructed to 
analyse the associated risk factor for GH and mH. Statistical significance was set at p < .05. All statistical analyses 
were conducted using SPSS for Windows, V. 18 (SPSS® , Chicago, Illinois, USA).
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